Topix Pharm

New York, United States Founded: 1989 • Age: 37 yrs
Skin care formulations are developed and marketed by Topix Pharmaceuticals.

About Topix Pharm

Topix Pharm is a company based in New York (United States) founded in 1989 by Declan Doogan. Topix Pharm has completed 2 acquisitions, including ClarityRx and Derma E. Topix Pharm offers products and services including Practice Branded Skincare, Anti-Aging Products, and Acne Treatments. Topix Pharm operates in a competitive market with competitors including Revance Therapeutics, Castle Creek Pharma, Dermavant, Sol-Gel Technologies and Bausch Health, among others.

  • Headquarter New York, United States
  • Founders Declan Doogan
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website topixpharm.com
  • Social LinkedIn X Facebook Instagram
  • Legal Name Topix Pharmaceuticals, Inc.
Operational Areas
Key Metrics

Products & Services of Topix Pharm

Topix Pharm offers a comprehensive portfolio of products and services, including Practice Branded Skincare, Anti-Aging Products, and Acne Treatments.

Practice Branded Skincare
Skincare Products

High-efficacy formulations for medical practices and patients.

Anti-Aging Products
Skincare

Solutions for reducing aging signs and improving skin health.

Acne Treatments
Skincare

Effective products targeting acne and related skin concerns.

Funding Insights of Topix Pharm

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Topix Pharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2016–Private Equity Round––
Valuation history

1 investors in total: 1 institutional.

Investors in Topix Pharm

Topix Pharm has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include New Mountain Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
New Mountain Capital manages investments in private equity, credit, and net lease strategies.
–newmountaincapital.com-
Premium access

Investor details for Topix Pharm

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Topix Pharm

32 people are tracked at Topix Pharm (11 in leadership, 21 in team).

NameRoleGroup
Declan Doogan
FounderLeadership
Burt Shaffer
CEO & PresidentLeadership
Lauren Giacobbe
Regional Sales DirectorLeadership
Mike Leclair
Regional DirectorLeadership
Joe Ragosta
Vice President Of SalesLeadership
Alfonse Fauci
Chief Financial OfficerLeadership
Beth Lichtenberger
National Training & Education DirectorLeadership
Ovidiu A. Vasian
Director Of EngineeringLeadership
Brenda Wu
President/CEOLeadership
Jordane Perkins
Associate Director Of National AccountsLeadership
Stephen Dengel
Vice President, Fulfillment OperationsLeadership
Jacqueline Suver
Business Development SpecialistTeam
Joy Norman (Leeland)
Business Development SpecialistTeam
Dina Bantit
Business Development SpecialistTeam
Kelly Quinn
Business Development SpecialistTeam
Dana Whalen
Territory Sales ManagerTeam
Cindy Taylor
Credit/collections ManagerTeam
Becca Russo
Business Development SpecialistTeam
Kendall Connell Bullard
Business Development SpecialistTeam
Felisha Chapman
Business Development SpecialistTeam

12 more people are available in the full profile.

Premium access

Complete people profiles for Topix Pharm

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Topix Pharm

Topix Pharm has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include ClarityRx and Derma E.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
ClarityRx is engaged in providing medical-grade, plant-based skincare solutions.
clarityclinicalskincare.comNewbury Park, United States2003Feb 2019••••
Manufacturer of vegan, cruelty-free skincare products
dermae.comSimi Valley, United States1984May 2018••••
Premium access

Complete acquisition details for Topix Pharm

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Topix Pharm

4 dated milestones of Topix Pharm across 30 years, from founding to its latest funding, stage changes and deals.

  1. Founded Topix Pharm is founded.
  2. Funding First funding round.
  3. Acquisition Acquires Derma E.
  4. Acquisition Acquires ClarityRx.

Competitors of Topix Pharm

Topix Pharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Revance Therapeutics, Castle Creek Pharma, Dermavant, Sol-Gel Technologies and Bausch Health, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
revance.com2002Newark, United States$154.56M597
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
castlecreekpharma.com2015Basking Ridge, United States$663.15M72
Drugs for skin diseases, ENT disorders, and rare diseases such as urea cycle disorders
dermavant.com2016Phoenix, United States$160M–
Small molecule therapeutics for inflammatory skin diseases are developed.
sol-gel.com1998United States$9M–
Developing topical drug products for the treatment of rosacea, acne and interdigital tinea pedis.
bauschhealth.com1960Laval, Canada–808
Therapeutics for multiple diseases including dermatology and neurology are developed.
hugel.co.kr2001Chuncheon-si, South Korea––
Therapeutics in aesthetics are developed, including botulinum toxin products.
kythera.com2005Calabasas, United States$144.82M113
Prescription products for aesthetic medicine are developed and commercialized.
sofregen.com2014Medford, United States$17.8M8
Silk-derived biomaterials are developed for soft tissue repair in surgery.
pyramidbio.com2015Waltham, United States$71.19M3
Small molecules are developed for dermatology and oncology treatments.
Premium access

Detailed competitors of Topix Pharm

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Topix Pharm

The website of Topix Pharm (topixpharm.com) receives about 4.5K visits a month.

  • Monthly visits
    4.5K

    ▲ 29.2% vs previous month

Similar websites

Websites whose visitors overlap most with Topix Pharm. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
hctgroup.com
100%
8.4K#2,604,541View details
ladyburd.com
96%
–#2,667,948View details
goodvara.com
goodvara.com
82%
–#6,958,047–
lovelyskin.com
75%
868.8K#56,118View details
trilogylaboratories.com
trilogylaboratories.com
74%
–#2,112,348–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 17 similar websites and full traffic analytics for Topix Pharm

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 17 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Topix Pharm

Premium access

Complete news archive for Topix Pharm

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Topix Pharm

10 companies that operate in the same segment as Topix Pharm (Dermatology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
2002Newark, New Jersey, United StatesUSD 154.56 MUSD 234.04 M597
Diagnostic tests for cancer prognosis are provided.
2008Friendswood, Texas, United StatesUSD 61.97 MUSD 344.23 M761
Developer of drugs for treating dermatology diseases
1908Copenhagen, DenmarkUSD 560.38 M––
Skincare, beauty, and wellness services provided by VLCC across multiple countries.
1989Delhi, Delhi, India–––
Adhesive patch biopsies for skin cancer detection are provided.
1996San Diego, California, United StatesUSD 24.37 MUSD 15.3 M259
AI-powered drug discovery platform for various diseases
2016New York, New York, United StatesUSD 608 M––
Immunotherapeutic solutions for dermatological conditions are developed.
2016Westlake Village, California, United StatesUSD 94.5 MUSD 376.07 M342
Targeted small molecules are developed for oncology treatments.
2010Singapore, SingaporeUSD 100 M––
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured.
2014Pune, Maharashtra, IndiaUSD 25.97 MUSD 18.15 M508
Novel dermatologic therapies are developed for skin conditions.
2012Malvern, Pennsylvania, United StatesUSD 82 MUSD 7.83 M64
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Topix Pharm

Topix Pharm was founded in 1989 and raised its 1st funding round 27 years after it was founded.

Topix Pharm is headquartered in New York, United States. It is registered at New York, New York, United States.

Burt Shaffer is the current CEO of Topix Pharm.

Topix Pharmaceuticals was established in 1989 in New York, United States, with a focus on research and development in the skin care sector. Formulations are created for categories such as anti-oxidants, cleansers, body care, eye care, exfoliators, moisturizers, sunscreens, and toners. Brands offered include Replenix, Citrix, Glycolix, SRS, Derma Topix, Rebrightalyze, and Solvere. Operations center on quality product development and marketing.

Topix Pharm's top competitors include Revance Therapeutics, Dermavant and Bausch Health.

Topix Pharm offers Practice Branded Skincare, Anti-Aging Products, and Acne Treatments.

Topix Pharm has made 2 acquisitions, including ClarityRx, and Derma E.

Topix Pharm has 1 investor. Key investors include New Mountain Capital.

Topix Pharm operates through Topix Pharmaceuticals, Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available